All News Talis Biomedical Corporation

Equities

TLIS

US87424L2079

Delayed Nasdaq Other stock markets 04:00:00 2024-05-07 pm EDT			5-day change	1st Jan Change
9.3 ^USD	+1.53%		+7.89%	+24.83%

Apr. 02	North American Morning Briefing : Stocks Seen -2-	DJ
Mar. 28	Talis Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Talis: Q1 Earnings Snapshot	08:18am	AQ
North American Morning Briefing : Stocks Seen -2-	Apr. 02	DJ
Talis Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
North American Morning Briefing : Stock Futures Muted; Nvidia Slips in Offhours Trading	Nov. 22	DJ
Talis: Q3 Earnings Snapshot	Nov. 14	AQ
Talis Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash	Nov. 14	AQ
Talis Biomedical Announces Exploration of Strategic Alternatives	Nov. 13	CI
Talis Biomedical Corporation Announces Resignation of Melissa Gilliam from its Board of Directors, as Member of Nominating and Corporate Governance Committee and as Member and Co-Chairperson of Science, Technology and Clinical Affairs Committee	23-09-01	CI
BTIG Adjusts Talis Biomedical's Price Target to $5 From $5.25, Keeps Sell Rating	23-08-16	MT
Talis: Q2 Earnings Snapshot	23-08-10	AQ
Talis Biomedical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Transcript : Talis Biomedical Corporation, Q2 2023 Earnings Call, Aug 10, 2023	23-08-10
Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update	23-08-10	AQ
Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023	23-08-03	AQ
Talis Biomedical Corporation Announces Resignation of Andrew A. Lukowiak as President and Chief Scientific Officer	23-08-02	CI
Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)	23-08-02	AQ
New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product Menu	23-07-27	AQ
Talis Biomedical Corporation Announces New Data Supporting the Development of Its Planned CT/NG/TV and Vinal Infections Panels	23-07-27	CI
Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement	23-07-24	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Talis Biomedical Corporation

Equities

TLIS

US87424L2079

All News

Filters